Paraganglioma is a rare type of neuroendocrine tumor that grows from nerve tissue found along blood vessels and nerves, most often in the head and neck or near the spine and abdomen. Many paragangliomas grow slowly and may cause no signs at first, but some make stress hormones that can trigger high blood pressure, pounding headaches, sweating, palpitations, and anxiety-like episodes; others cause local issues such as a neck lump, hoarseness, ringing in one ear, or hearing loss. It can appear at any age but is often found in adults, and a portion are linked to inherited gene changes, so genetic testing can sometimes clarify why paraganglioma appears in families. Treatment depends on size, location, and hormone activity and may include careful monitoring, surgery, and when needed, radiation or targeted therapies; blood pressure medicines help control hormone-related symptoms. The outlook varies—most are benign but some can spread—and with experienced care many people live long and full lives.
How many people live with Paraganglioma?
Worldwide, pheochromocytoma and paraganglioma (PPGL) together are estimated to affect about 480,000 to 640,000 people as of 2022; paragangliomas may make up about 15% to 20% of PPGL, which suggests roughly 70,000 to 130,000 people live with paraganglioma globally (this is an estimate, not a direct count). In the United States, using the same 2022 ranges suggests about 20,000 to 26,000 people with PPGL, of whom roughly 3,000 to 5,000 may have paraganglioma.
Overview
ParagangliomaSymptoms
Paraganglioma symptoms vary or may be absent. Early symptoms of paraganglioma can include pounding headaches, palpitations, sweating, and high blood pressure from hormone release. Tumors in the neck, chest, or abdomen may cause a lump, hoarseness, hearing changes, abdominal pain.
Outlook and prognosis
Many living with paraganglioma do well, especially when tumors are found early and fully removed. Slow-growing behavior is common, and careful follow-up helps catch regrowth or new tumors. Outlook varies by tumor location, hormone activity, genetics, and spread.
Causes and risk factors
Paraganglioma arises; cases are linked to inherited or gene changes, especially SDHx genes, and syndromes like VHL, MEN2, or NF1. Family history increases risk. Sporadic cases occur; chronic hypoxia (including high altitude) may contribute, and no lifestyle risks are known.
Genetic influences
Genetics play a major role in paraganglioma. Around one‑third to one‑half are linked to inherited variants, especially in SDHx genes. Genetic testing can guide screening, treatment choices, and family risk assessment, even when there’s no clear family history.
Diagnosis
Paraganglioma is diagnosed using blood or urine tests for catecholamine-related hormones and imaging, usually MRI or CT, sometimes specialized nuclear scans. Doctors also review symptoms and exam findings. Genetic testing is often recommended to assess inherited risk.
Treatment and drugs
Treatment for paraganglioma often combines precise surgery with focused radiation when tumors are hard to remove or recur. Doctors may use targeted medicines, somatostatin analogs, or chemotherapy for spread or hormone‑secreting tumors. Ongoing imaging and blood/urine monitoring guide adjustments.
Symptoms
Paraganglioma can cause hormone surges or press on nearby structures, so symptoms depend on location and whether it makes adrenaline-like hormones. Many notice sudden spells of pounding heartbeat, sweating, and throbbing headache, sometimes with very high blood pressure. Early symptoms of paraganglioma can be subtle and may come and go. Symptoms vary from person to person and can change over time.
Blood pressure may be high all the time or spike during sudden hormone surges. These surges are often linked to adrenaline-like releases from a paraganglioma.
Sudden, throbbing headaches can last minutes to hours. They often come with sweating, palpitations, and high blood pressure when the paraganglioma releases stress hormones.
The heart may race or pound even at rest. Palpitations can feel like fluttering or thudding in your chest, throat, or neck.
Sweating can be sudden and profuse, even in a cool room. It often appears with headache, palpitations, or anxiety.
How people usually first notice Paraganglioma?
Many people first notice paraganglioma when a “spells” pattern shows up: pounding headaches, rapid heartbeat, sweating, paleness or flushing, and anxiety-like surges that come in waves, sometimes with very high blood pressure—especially with tumors that make adrenaline-like hormones. Others discover it because of a painless, slow-growing lump in the neck or behind the ear, new-onset hearing changes or ringing on one side, or hoarseness—features doctors spot during an exam or imaging done for another reason. In families with known genetic risk, the first signs of paraganglioma may be found earlier through screening scans or blood/urine tests, which is often how paraganglioma is first noticed before symptoms begin.
Types of Paraganglioma
Paraganglioma has several well-recognized types based on where the tumor starts and whether it makes excess adrenaline-like hormones. These variants can feel quite different in day-to-day life—from silent, slow-growing neck masses to sudden pounding headaches with racing heart. Not everyone will experience every type. When people talk about types of paraganglioma, they often mean one of these kinds, and understanding the types of paraganglioma can clarify why symptoms vary so much.
Head and neck
These usually form around the carotid artery, along the vagus nerve, or in the middle ear area. They often do not make hormones, so symptoms may be a painless neck lump, a pulsing sound in one ear, hoarseness, or trouble swallowing. Growth is typically slow but can affect nearby nerves.
Adrenal-related (pheochromocytoma)
This arises in the adrenal gland and is closely related to paraganglioma. It commonly produces hormones that trigger spells of headache, sweating, palpitations, and high blood pressure. Episodes may come in bursts or persist if hormone release is constant.
Thoracic paraganglioma
These start in the chest near the heart, lungs, or major vessels. Some make hormones and cause blood pressure spikes, while others are silent and found on scans. Pressure on nearby structures can cause chest discomfort or shortness of breath.
Abdominal paraganglioma
These form along nerves near the kidneys or major abdominal vessels. Hormone-secreting tumors can cause episodes of flushing, tremor, and hypertension; non-secreting ones may cause vague abdominal or back pain. They are sometimes found during imaging done for other reasons.
Pelvic paraganglioma
These occur in the pelvis, including near the bladder. Hormone release can cause blood pressure surges during urination, along with palpitations or headache. Non-secreting tumors may present as a pelvic mass or urinary changes.
Secretory (functional)
These tumors release adrenaline-like hormones into the bloodstream. People may have episodic headaches, sweating, tremor, anxiety, and high blood pressure, sometimes triggered by stress, surgery, or certain medicines. Monitoring metanephrines in blood or urine helps confirm this type.
Non-secretory (nonfunctional)
These do not release measurable hormones. Symptoms often come from size or location, such as a neck lump, hoarseness, ear ringing, or pressure-related pain. Blood pressure is usually unaffected unless another cause is present.
Hereditary variants
Many paragangliomas are linked to inherited gene changes, especially in SDHx genes. People with these variants may develop tumors at younger ages, in multiple locations, or on both sides. Family-based genetic counseling and periodic screening can help with early detection.
Can I slow down the onset of symptoms?
There’s no clear evidence that lifestyle changes can delay when paraganglioma symptoms begin, and healthy habits have not been shown to prevent these tumors. If you have an inherited risk or a past paraganglioma, following guideline-based screening—such as regular blood or urine tests for hormone levels, blood pressure checks, and imaging—can find tumors early and may reduce the chance of severe symptoms. Staying connected with a care team, including a genetics counselor and a hormone tumor specialist, can help you act early, though it can’t guarantee prevention.
What genetics can tell you about symptoms
Some inherited changes in SDHB are linked with paragangliomas that form in the abdomen, often causing surges of headache, palpitations, sweating, and high blood pressure. Variants in SDHD or SDHC more often affect head and neck areas, leading to painless lumps, hearing changes, or hoarseness.
Causes and risk factors
Paraganglioma can develop without a clear cause, but several factors can raise the chance of it occurring. About 30–40% are linked to inherited changes in certain genes; a family history or being diagnosed at a younger age makes a genetic cause more likely. Having a gene change doesn’t mean you’ll definitely develop the condition. Long-term low oxygen exposure—for example, living at high altitude or having heart or lung disease that keeps oxygen levels low—can stimulate the nerve-based cells these tumors arise from and increase risk. There are no proven lifestyle causes; if you have known risk factors for paraganglioma, consider genetic counseling and regular follow-up, especially after a related adrenal tumor or when multiple tumors run in the family.
What are the most common causes or risk factors?
The strongest risk factor is an inherited gene change passed down in the family—about 30% to 40% of paragangliomas are hereditary. Risk is higher if there’s a family history or a known inherited syndrome linked to these tumors; for many others, the cause isn’t known. Long-term low oxygen in the body—such as living at high altitude or having certain long-standing heart or lung conditions that reduce blood oxygen—may also raise the chance.
Environmental and biological risk factors
Paraganglioma risk can be influenced by factors that change how much oxygen your tissues sense over time. Doctors often group risks into internal (biological) and external (environmental). These influences do not guarantee you’ll develop paraganglioma, and they don’t predict early symptoms of paraganglioma, but they can flag who may benefit from closer follow-up.
Long-term residence above about 2,000 meters (6,500 feet) is linked with higher rates of certain paragangliomas, especially near the carotid body in the neck. Lower oxygen pressure at altitude can chronically stimulate these oxygen-sensing cells. The added risk tends to rise with longer exposure.
Longstanding lung conditions that keep oxygen levels low can raise the chance of paraganglioma in oxygen-sensing tissues. Repeated low-oxygen signals may drive cell growth over many years. The effect often tracks with how long and how low oxygen levels stay.
Birth heart conditions that keep blood oxygen low for years are associated with a higher likelihood of paraganglioma, particularly at the carotid body. The longer the body experiences low oxygen, the higher this risk appears to be. Even after repair, earlier years of low oxygen may still influence risk.
Repeated breathing pauses at night cause dips in oxygen that can stimulate the carotid body. This pattern has been linked to enlarged carotid bodies and is being studied as a possible contributor to paraganglioma risk.
Genetic risk factors
About one in three to four cases of paraganglioma are linked to inherited gene changes. Carrying a genetic change doesn’t guarantee the condition will appear. Different genes influence where tumors arise and how likely they are to return or spread. Inherited forms can start younger, so recognizing early symptoms of paraganglioma in families with a known variant can support timely checks.
SDHB variants: Strongly linked to paraganglioma outside the adrenal glands and a higher chance of spread. Tumors may appear at younger ages and can be multiple.
SDHD variants: Often cause multiple head-and-neck paragangliomas. Disease risk usually appears when the variant is inherited from the father due to a parent-of-origin effect.
SDHC variants: Typically associated with head-and-neck paraganglioma that is often benign. The overall risk of spread is lower than with SDHB.
SDHA variants: A less common cause of paraganglioma with variable, often later onset. Some families show lower overall chance of developing tumors.
SDHAF2 variants: A rare cause that mainly leads to head-and-neck paragangliomas. Disease generally occurs when inherited from the father due to a strong parent-of-origin effect.
VHL gene (VHL): Part of von Hippel–Lindau syndrome, which raises the risk of adrenal pheochromocytoma and some paragangliomas. Onset can be earlier than in noninherited cases.
RET gene (MEN2): Best known for adrenal pheochromocytomas in multiple endocrine neoplasia type 2, with occasional paraganglioma. Families often show tumors on both adrenal glands.
NF1 gene (NF1): In neurofibromatosis type 1, there is an increased risk of adrenal pheochromocytoma and, less commonly, paraganglioma. Many are found in adulthood.
TMEM127 variants: Increase risk for adrenal tumors and some paragangliomas. Tumors are often benign, and age at diagnosis varies.
MAX variants: Linked to adrenal and extra-adrenal tumors, including paraganglioma. Bilateral adrenal tumors are more frequent in these families.
FH variants: Usually associated with a tumor syndrome that includes kidney cancer and skin or uterine growths, and can also cause paraganglioma. Some tumors may behave more aggressively.
EPAS1 (HIF2A): Can lead to paraganglioma and high red blood cell counts (polycythemia). Tumors may produce adrenaline-like hormones.
EGLN1 (PHD2): A rare cause of paraganglioma, sometimes with polycythemia. Overall likelihood of developing a tumor appears low.
SLC25A11 variants: Rare changes linked to paraganglioma, including metastatic disease in some reports. Family patterns are still being clarified.
MDH2 variants: An uncommon cause of paraganglioma. Tumor behavior varies, and data remain limited.
DLST variants: A rare susceptibility gene tied to paraganglioma and pheochromocytoma. Reported frequency is low, but risk is increased compared with the general population.
Autosomal dominant: A single altered copy of a risk gene can raise the chance of paraganglioma. Any child has a 50% chance of inheriting the variant from an affected parent.
Parent-of-origin: For SDHD and SDHAF2, disease risk mainly occurs when the variant comes from the father. People who inherit the variant from their mother often stay unaffected but can pass it on.
Mosaicism: Some people carry the genetic change in only a portion of their cells. This can lead to later onset, fewer tumors, or negative results on some tests.
De novo changes: A new genetic change can arise in someone with no family history. That person can still pass the paraganglioma risk to children.
Variable penetrance: Not everyone with a risk variant develops paraganglioma. Age at diagnosis, hormone output, and number of tumors can differ widely by gene and between relatives.
Lifestyle risk factors
Paraganglioma isn’t known to be caused by lifestyle habits, but day-to-day choices can influence blood pressure surges, symptom flares, and how smoothly care goes. In other words, most research does not identify clear lifestyle risk factors for paraganglioma, yet certain triggers can make episodes more likely or more intense. Risk is more of a probability than a promise. Small, steady changes can help reduce spikes, support testing accuracy, and ease treatment plans.
Caffeine, energy drinks, some pre‑workout powders, and many cold decongestants can push adrenaline-like effects and trigger palpitations or headaches. Limiting or avoiding these products may reduce sudden blood pressure spikes.
A salty diet raises blood pressure and can intensify symptoms in people with paraganglioma. Choosing lower‑sodium meals and checking labels can help steady readings.
All‑out sprints, max lifts, or breath‑holding during effort can sharply raise blood pressure. Opting for guided, moderate activity with smooth breathing is often safer.
Alcohol can cause blood pressure swings and worsen pounding headaches or flushing. Keeping intake low or pausing alcohol may lessen episodes.
Risk prevention
Paraganglioma can’t usually be prevented outright, but you can lower complications and catch tumors earlier. If it runs in your family, genetic testing and planned monitoring often make the biggest difference. Knowing your risks can guide which preventive steps matter most. Day to day, the goal is steady blood pressure, trigger awareness, and regular check-ins with a care team that knows this condition well.
Ask about testing for known risk genes when paraganglioma is in the family or diagnosed at a young age. Finding a gene change guides who needs screening, how often, and which scans or labs to use. It can also inform relatives about their own risks.
Set a schedule for hormone blood or urine tests and periodic MRI scans to spot tumors early. Early detection limits emergencies and allows safer, planned treatment. Plans differ by age, gene, and past findings.
Check blood pressure regularly at home and during clinic visits. Treat high readings promptly to reduce stroke or heart strain from hormone surges. Share logs with your care team to fine‑tune medications.
Before new prescriptions or surgery, tell clinicians about paraganglioma risk. Some drugs, decongestants, stimulants, and certain antidepressants can trigger blood‑pressure spikes. Anesthesia plans can be adjusted to prevent dangerous surges.
Can you prevent Paraganglioma?
Paraganglioma can’t be reliably prevented. Many cases are tied to inherited gene changes you can’t control, but if it runs in your family, genetic counseling and regular checkups or screening can help find problems early. Long-term low‑oxygen exposure (for example, living at very high altitude or having untreated conditions that lower blood oxygen) has been linked to higher risk, so addressing those factors may help, but this hasn’t been proven.
Transmission
Paraganglioma is not contagious—you can’t catch it from someone or pass it on through everyday contact. Most paragangliomas happen sporadically, but about 30% to 40% are linked to an inherited change in a single gene. When paraganglioma is inherited, it usually follows an autosomal dominant pattern, meaning each child of a parent who carries the gene change has a 50% chance of inheriting it, though not everyone who inherits it will develop a tumor. Paraganglioma can also appear in someone with no family history because of a new genetic change that starts in that person. If you’re wondering how paraganglioma is inherited or about the genetic transmission of paraganglioma, a genetics professional can help explain your personal and family risk.
When to test your genes
Consider genetic testing at diagnosis of any paraganglioma, especially if you’re younger than 45, have multiple tumors, bilateral adrenal tumors, metastatic disease, or a family history. Results can guide surveillance plans, surgery timing, and medication choices for you. Testing also helps relatives decide whether they need screening.
Diagnosis
Paraganglioma is often suspected when people have unexplained spikes in blood pressure, pounding heartbeats, headaches, or sweating spells that disrupt daily life. The diagnosis of Paraganglioma usually combines symptom review, hormone testing, and scans to locate the tumor. After reviewing your symptoms, the next step often involves tests that look for specific hormone byproducts in blood or urine and imaging to map where the tumor sits. Because some tumors are quiet and don’t release hormones, doctors use several tools together to get a clear answer.
Doctors ask about headache, palpitations, sweating, anxiety, or episodes of high blood pressure, plus any family history of similar tumors. A focused exam looks for signs like blood pressure changes or neck masses.
Labs measure metanephrines, the breakdown products of adrenaline-like hormones, in blood or a 24-hour urine collection. Markedly elevated levels support the diagnosis and help flag tumors that release hormones.
Readings are taken seated and standing, and sometimes with a 24-hour monitor. This helps capture sustained hypertension or sudden surges that can occur with paraganglioma.
Imaging of the chest, abdomen, pelvis, or head and neck is used to find the tumor and define its size and nearby structures. MRI is often preferred for head and neck tumors or when avoiding radiation is important.
How is Paraganglioma diagnosed?
Doctors diagnose paraganglioma by asking about symptoms, checking blood or 24-hour urine for extra levels of adrenaline-like hormones and their breakdown products (though some tumors do not make hormones), and using imaging such as MRI or CT to find the growth; in some cases, special scans are used to highlight these cells. Because taking a tissue sample (biopsy) can be risky when the tumor makes these hormones, doctors usually avoid it and confirm the type after removal under careful preparation. Genetic testing is often offered to look for inherited changes that can guide care and family screening, but the core diagnosis relies on the lab tests and scans.
Stages of Paraganglioma
Paraganglioma does not have defined progression stages. This is because these tumors behave differently depending on where they start and their biology—some remain stable for years, while others spread to lymph nodes or distant organs, so doctors focus on whether it has spread (metastatic) and other risk features rather than numbered stages. Different tests may be suggested to help confirm the diagnosis and map out the extent, including blood or urine checks for stress hormones, imaging such as MRI or CT, and sometimes specialized nuclear scans; because early symptoms of paraganglioma can be subtle, this stepwise approach is common. Ongoing care usually involves regular scans and lab checks to watch for change, and many are offered genetic testing to understand personal and family risk.
Outlook and prognosis
Looking ahead can feel daunting, but many people with paraganglioma do well for years, especially when tumors are found early and removed or controlled. Prognosis refers to how a condition tends to change or stabilize over time. Most paragangliomas grow slowly. Some stay stable for long stretches, causing few symptoms beyond pain, pressure, or hormone-related issues like headaches, palpitations, and high blood pressure. The risk of spread (metastasis) varies by tumor location, size, and specific gene changes. When paraganglioma is confined to its original site and fully treated, long-term survival is generally high.
The outlook is not the same for everyone, but genetic factors can shape it. People with certain inherited variants—such as changes in SDHB—have a higher chance of metastatic disease and may need closer follow-up. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. If paraganglioma becomes metastatic, it’s considered a chronic condition that can often be managed for many years with a combination of surgery, targeted radiation, medicines that block hormone effects, and newer systemic therapies. Mortality is most closely tied to whether the tumor spreads and whether hormone surges are controlled; severe, uncontrolled catecholamine release can be dangerous, but careful blood pressure management lowers that risk.
Over time, most people with paraganglioma settle into a rhythm of periodic imaging, lab checks, and visits with specialists. Early symptoms of paraganglioma—such as episodic pounding headaches, sweating, or spikes in blood pressure—are worth bringing up quickly, since faster diagnosis and treatment can improve outcomes. With ongoing care, many people maintain normal daily routines, work, and exercise, adjusting around treatment cycles and follow-up scans. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Paraganglioma can have a long arc, with effects shaped by the tumor’s location, hormone activity, treatment, and whether it returns. Long-term effects vary widely, and they may look different for head and neck tumors than for those in the chest or belly. Even after treatment, some people find that early symptoms of paraganglioma—such as pounding headaches, sweating, or a racing heartbeat—can recur if hormone-secreting cells persist or the tumor grows back. Doctors often watch for late nerve changes or blood pressure issues that may unfold over years.
Paraganglioma can come back months or years after initial treatment. This risk is higher with hereditary forms or larger tumors.
A subset of paragangliomas spreads to lymph nodes, bone, liver, or lungs. Metastases can appear many years later and shape long-term survival.
Tumors that release stress hormones can cause ongoing high blood pressure, headaches, and palpitations. These effects may flare under stress or illness and can persist if hormone-producing cells remain.
Long-standing hormone surges may lead to heart muscle weakness, rhythm problems, or stress cardiomyopathy. Some heart changes improve after tumor control, while others can leave lasting effects.
How is it to live with Paraganglioma?
Living with paraganglioma often means juggling regular scans, lab checks, and specialist visits while keeping an eye on symptoms like headaches, palpitations, sweating, or swings in blood pressure that can flare with stress, pain, or certain medications. Many people feel well between visits, but the uncertainty—Will it grow? Could it spread?—can weigh on mood, sleep, and work or school plans, and may nudge family members to consider genetic counseling if an inherited form is suspected. Partners, relatives, and friends may take on roles as appointment companions or blood pressure helpers, and they, too, can feel the strain, so sharing clear plans for emergencies and leaning on support groups or counseling can help everyone. With a knowledgeable care team, a personalized monitoring plan, and attention to stress management, most people find a steady rhythm that keeps daily life active and meaningful.
Treatment and drugs
Paraganglioma treatment focuses on safely removing or controlling the tumor, managing hormones if it produces them, and reducing the risk of spread. Surgery is the main treatment when possible; before surgery, people with hormone‑secreting paraganglioma usually take alpha- and sometimes beta‑blocking medicines to steady blood pressure and heart rate. If the tumor can’t be fully removed or has spread, options can include targeted radiation (such as stereotactic radiotherapy), radiopharmaceuticals like 131I‑MIBG or 177Lu‑DOTATATE when the tumor shows uptake, and systemic therapies such as temozolomide or other chemotherapy in selected cases. Treatment plans often combine several approaches, and doctors also monitor for and treat high blood pressure, headaches, sweating, and anxiety related to hormone surges. When treatment is tailored to your genes, it’s often called personalized medicine, so genetic testing can guide follow‑up and family screening as well as therapy choices.
Can you cure Paraganglioma?
Some paragangliomas can be cured if the tumor is in one spot and doctors can remove it completely with surgery. When tumors have spread, are in hard‑to‑reach places, or there are several at once (including in families where these tumors run), a full cure may not be possible, but treatments like radiation and medicines can shrink or slow the tumor and control symptoms such as high blood pressure from hormone surges. Ongoing checkups are important because these tumors can come back years later, even after treatment.
Non-drug treatment
Paraganglioma care often includes non-drug treatments that aim to control the tumor, protect nerve function, and support day-to-day life. Non-drug treatments often lay the foundation for long-term management alongside any needed medications. Some approaches focus on careful monitoring, especially when tumors are small or slow-growing, while others aim to remove or control the tumor without medicine. Knowing the early symptoms of paraganglioma and staying on a structured follow-up plan can help catch changes promptly.
Regular check-ins with imaging and hearing or nerve checks track a slow-growing paraganglioma over time. This approach can be suitable for small tumors or when surgery would carry higher risks.
Surgeons aim to remove the tumor while preserving nearby nerves and blood vessels. Surgery can be curative when the paraganglioma is in a location that allows safe removal.
Targeted beams can slow or stop tumor growth when surgery isn’t possible or carries high risk. It can also help protect nerve function in head and neck paraganglioma.
A highly focused form of radiation treats the tumor in one or a few sessions. It can control growth while limiting radiation to healthy tissue.
Your genes may have an impact on how drugs work for you
Drugs for paraganglioma can work differently based on genes that affect how tumors make catecholamines and how your liver enzymes process medicines. Genetic testing can guide choices and dosing for alpha-blockers, beta-blockers, chemotherapy, and targeted therapies to improve safety and benefit.
Pharmacological treatments
Paraganglioma medicines aim to control hormone-related spikes, stabilize blood pressure, and treat tumors that can’t be fully removed or have spread. Some drugs are used short-term to prepare for surgery, while others are longer-term options for metastatic disease. Not everyone responds to the same medication in the same way. Some medicines are used to control dangerous hormone surges that drive many early symptoms of paraganglioma.
Phenoxybenzamine or doxazosin lower the effect of excess adrenaline-like hormones and smooth out blood pressure swings. They are used before surgery and in symptomatic unresectable disease to prevent dangerous crises.
Propranolol or metoprolol control fast heart rate and tremor after alpha blockade is in place. Starting them before alpha blockade can raise blood pressure, so doctors add them only after adequate alpha control.
Metyrosine reduces the body’s production of catecholamines to tame severe hormone excess. It is added when alpha and beta blockers aren’t enough or before high-risk surgery.
Amlodipine or nicardipine help stabilize blood pressure and may be used when alpha blockers are not tolerated or need support. They can be combined carefully with other blood pressure medicines.
Genetic influences
Genetics play a major role in paraganglioma for many people. About 30 to 40 percent of people with paraganglioma have an inherited change in a gene that raises risk. Most often these involve the SDH genes (SDHB, SDHD, SDHC), which help cells use energy and oxygen; less commonly, changes in VHL, RET, NF1, TMEM127, MAX, and others are found. Having a gene change doesn’t always mean you will develop the condition. The pattern is usually autosomal dominant, so one altered copy can raise risk, and in a few genes such as SDHD, tumors tend to appear mainly when the change is inherited from the father. Genetic testing for paraganglioma can clarify your risk, shape lifelong screening plans for you and your relatives, and sometimes influence treatment and how closely doctors monitor for spread, especially with SDHB changes.
Is Paraganglioma genetic?
Genetics play a major role in paraganglioma. Around one‑third to one‑half are linked to inherited variants, especially in SDHx genes. Genetic testing can guide screening, treatment choices, and family risk assessment, even when there’s no clear family history.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a routine part of being human and are widespread in the general population. Most variants do not directly affect health; they simply reflect normal human diversity. For many genes, having a variant linked to a condition suggests a possible connection rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In certain situations, however, a single, well-studied variant in a specific gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
Genetic changes in paraganglioma—both inherited and within the tumor—can guide which treatments are most likely to help. Differences in genes such as SDHB, SDHD, VHL, RET, MAX, or TMEM127 may hint at how fast the disease could grow and point toward treatment options for paraganglioma like MIBG radiotherapy, somatostatin‑targeted therapy, or specific chemotherapies. For example, SDHB‑related tumors are more prone to spread and, in some cases, may respond better to the chemotherapy drug temozolomide.
Genetics can also influence how your body handles medicines used before surgery to control blood pressure and heart rate, such as alpha‑blockers and beta‑blockers; some people break down certain beta‑blockers quickly and may need higher doses, while others process them slowly and have more side effects. Alongside medical history and imaging, genetic testing can sometimes help doctors match therapies—like radiopharmaceuticals or targeted drugs—to your tumor’s biology. Genes aren’t the whole story, though; age, kidney and liver function, other medicines, and scan results often shape the final plan.
Interactions with other conditions
When paragangliomas release stress hormones, existing conditions like high blood pressure, heart disease, or irregular heartbeats can become harder to control. These hormone surges may also make blood sugar tougher to manage in diabetes and can resemble anxiety or panic, which may hide early symptoms of paraganglioma. Certain diseases may “overlap,” meaning some people have inherited syndromes that raise the chance of paraganglioma along with other tumors, including pheochromocytoma, kidney cancer (in VHL), or medullary thyroid cancer (in MEN2). In these situations, treatment for paraganglioma needs careful coordination, since medicines or surgery for one tumor can affect testing, anesthesia, or recovery for the others. In the head and neck, thyroid problems can exist at the same time, and past neck radiation or surgery may complicate imaging and future procedures. It helps to discuss with your care team how one diagnosis might affect another so your plan covers the full picture.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Paraganglioma?
Spells of pounding heartbeat, sweating, headache, and high blood pressure from a paraganglioma can look like panic attacks or anxiety, an overactive thyroid, irregular heart rhythms, sleep apnea (breathing pauses during sleep), side effects of stimulants or decongestants, or plain high blood pressure. A closely related adrenal gland tumor called pheochromocytoma can cause almost identical symptoms and is often checked for at the same time. If it shows up as a neck lump or a pulsing sound in one ear, it may be confused with thyroid nodules or an enlarged thyroid, salivary gland swelling, benign nerve tumors, middle-ear growths, or swollen lymph nodes from infection.
History
Throughout history, people have described sudden pounding heartbeats, sweating, and headaches that came in waves—episodes we now recognize in some with paraganglioma. Families and communities once noticed patterns of similar spells or early high blood pressure in certain relatives, hinting that the condition could run in families long before genes were part of the conversation.
First described in the medical literature as small nests of unusual cells found near blood vessels and nerves, paraganglioma was initially understood only through symptoms, later connected to hormone surges and dangerous spikes in blood pressure. In the early 20th century, pathologists began linking these growths to the body’s stress-signal system, explaining why some people felt jittery, flushed, or faint during episodes while others had few outward signs.
From these first observations, surgeons learned that removing a tumor could calm symptoms dramatically, but they also saw that careful preparation was crucial to avoid blood pressure crises during surgery. As medical science evolved, imaging scans made it easier to find hidden tumors in the neck, chest, or abdomen, and to distinguish paraganglioma from related tumors in the adrenal gland.
In recent decades, knowledge has built on a long tradition of observation. Researchers identified inherited changes in several genes—now known to be important in a sizeable share of paraganglioma cases—which helped explain why generations of similar symptoms sometimes appeared in the same family. This shifted care toward earlier screening for at-risk relatives and ongoing monitoring for those already diagnosed.
Over time, descriptions became more precise, separating tumors that release stress hormones from those that do not, and recognizing that paraganglioma can behave differently depending on its location. Doctors also learned that some tumors stay stable for years, while a smaller number can spread, shaping today’s follow-up plans and treatment choices.
Knowing the condition’s history helps explain current care: a blend of symptom awareness, blood and urine testing for stress hormones, imaging to map tumor sites, and genetic counseling when family patterns are present. What began as scattered reports of alarming episodes has grown into a clearer understanding that guides safer surgeries, tailored monitoring, and family-focused care for people living with paraganglioma.